Pathways Connecting Late-Life Depression and Dementia

Area of Science:

• Neuroscience
• Gerontology
• Psychiatry

Background:

• Late-life depression is frequently accompanied by cognitive impairment.
• Depression is linked to an increased risk of Alzheimer's disease (AD), suggesting a potential etiological role.
• Distinguishing between late-life depression and dementia is challenging due to overlapping symptoms and pathophysiology.

Purpose of the Study:

• To explore the overlapping pathophysiological substrates between late-life depression and dementia (including Alzheimer's disease).
• To identify common etiological factors and pathways that link these two conditions.
• To highlight potential synergistic and multifaceted treatment possibilities based on shared mechanisms.

Main Methods:

• Review of existing meta-analyses and scientific literature.
• Examination of proposed common pathways: stress response (cortisol), vascular factors, neuroinflammation (microglia, TGF-beta1), neurotrophin BDNF, amyloid beta accumulation, tau hypothesis, sex/gender differences, epigenetics, and the gut microbiota-brain axis.
• Analysis of clinical trial outcomes for amyloid-beta targeted therapies.

Main Results:

• Elevated cortisol levels, vascular risk factors, neuroinflammatory processes, and altered BDNF levels are implicated in both depression and dementia.
• Plasma amyloid beta-42 levels predict both late-onset depression and conversion to AD, though anti-amyloid therapies have shown limited success.
• Other potential common pathways include tau pathology, sex/gender influences, epigenetics, and the gut-brain axis.

Conclusions:

• Multiple overlapping pathophysiological mechanisms connect late-life depression and dementia.
• These shared pathways offer potential targets for novel, individualized treatment strategies.
• Further research into these commonalities is crucial for developing effective interventions.